Bulletin from the annual general meeting in EQL Pharma AB on 17 August 2022. Christer Fåhraeus was elected as new Chairman
Today, on 17 August 2022, the annual general meeting was held in EQL Pharma AB. All resolutions were adopted with the required majority of votes.Resolution on adoption of accounts and allocation of the company’s result The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income statement and the consolidated balance sheet. The annual general meeting also resolved to distribute the company’s result in accordance with the proposal from the board of directors in the annual report meaning that no dividends are paid for the financial